- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02490449
Dexlansoprazole MR in Nonerosive Reflux Disease
July 2, 2015 updated by: Su Jin Hong, Soonchunhyang University Hospital
This study aim is to compare the efficacy of Dexlansoprazole MR intake before and after breakfast in patients with nonerosive reflux disease.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
356
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Gyeonggi-do
-
Bucheon, Gyeonggi-do, Korea, Republic of, 420-767
- Digestive Disease Center, Department of Internal Medicine, Soonchunhyang University College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- NERD confirmed by gastroscopy
Exclusion Criteria:
- PPI medication within 2 weeks before enrollment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exprerimental group
medication after diet
|
Administration of drug after or before diet
|
Active Comparator: control group
medication before diet
|
Administration of drug after or before diet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Percentage (%) of patients free of reflux symptoms
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Su Jin Hong, Soonchunhyang University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (Anticipated)
December 1, 2015
Study Registration Dates
First Submitted
December 13, 2014
First Submitted That Met QC Criteria
July 2, 2015
First Posted (Estimate)
July 3, 2015
Study Record Updates
Last Update Posted (Estimate)
July 3, 2015
Last Update Submitted That Met QC Criteria
July 2, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Gastrointestinal Diseases
- Esophageal Motility Disorders
- Deglutition Disorders
- Esophageal Diseases
- Gastroesophageal Reflux
- Molecular Mechanisms of Pharmacological Action
- Enzyme Inhibitors
- Gastrointestinal Agents
- Anti-Ulcer Agents
- Proton Pump Inhibitors
- Dexlansoprazole
- Lansoprazole
Other Study ID Numbers
- SCHBC 2014-05-021-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nonerosive Reflux Disease
-
Xiyuan Hospital of China Academy of Chinese Medical...First Teaching Hospital of Tianjin University of Traditional Chinese Medicine and other collaboratorsRecruitingNonerosive Reflux DiseaseChina
-
Xiyuan Hospital of China Academy of Chinese Medical...Guangdong Provincial Hospital of Traditional Chinese Medicine; Wuhan No.1 Hospital and other collaboratorsUnknownNonerosive Reflux DiseaseChina
-
TakedaTerminatedGastroesophageal Reflux Disease | Non-erosive Reflux DiseaseSwitzerland, Netherlands
-
arpa pungrasameeCompletedNon-erosive Reflux Disease | Gastro-esophageal Reflux DiseaseThailand
-
Vanderbilt University Medical CenterCompletedGastroesophageal Reflux Disease (GERD) | Non-erosive Reflux Disease (NERD)United States
-
Daewoong Pharmaceutical Co. LTD.RecruitingNon-erosive Reflux Disease | Non-Erosive Gastro-Esophageal Reflux Disease | Non-Erosive Esophageal Reflux DiseaseKorea, Republic of
-
Brigham and Women's HospitalEndoGastric SolutionsNot yet recruitingGastroesophageal Reflux Disease (GERD) | Motility Disorder | Laryngopharyngeal Reflux (LPR) | Reflux Disease, Gastro-EsophagealUnited States
-
Mansoura UniversityWithdrawnGastroesophageal Reflux Disease
-
Cliniques universitaires Saint-Luc- Université...UnknownGastroesophageal Reflux DiseaseBelgium
-
King Chulalongkorn Memorial HospitalCompleted
Clinical Trials on Dexlansoprazole MR
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
TakedaCompletedGastroesophageal RefluxUnited States
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States, Poland, Bulgaria, India, South Africa, Canada, Peru, New Zealand, Australia, Lithuania, Slovakia, Hungary, Latvia, Germany, Czech Republic
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States, Canada, Czech Republic, Lithuania, Slovakia, Latvia, Estonia, Australia
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States, Poland, Bulgaria, India, Canada, Peru, Russian Federation, Australia, New Zealand, Czech Republic, Slovakia, South Africa, Latvia, Lithuania, Colombia, Germany
-
TakedaCompletedGastroesophageal Reflux DiseaseUnited States
-
TakedaCompletedGastroesophageal RefluxUnited States